Michael Mathieson

Michael Mathieson is a Senior Medicinal Chemist at BioAscent, where they are focused on the design and synthesis of small molecules as therapeutic agents for the treatment of tuberculosis. They previously held positions as a Senior Medicinal Chemist and Medicinal Chemist at Amphista Therapeutics Limited and worked as a Medicinal Chemist at the University of Dundee from 2015 to 2019. Earlier in their career, they were a Scientist and Associate Scientist at Redx Oncology in 2015. Michael earned a Master's Degree in Chemistry with Biochemistry from Heriot-Watt University and a Doctor of Philosophy in Organic Chemistry from the University of Glasgow.